Clinical Trial Update: Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating postoperative chemotherapy with or without bevacizumab in stage II/III rectal cancer was terminated with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Rectum
• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Adenocarcinoma of the Rectum, Stage II Rectal Cancer | Phase 3 | Status: TERMINATED | Results posted: 2016-02-26